" Since the defendant has not discharged his evidentiary burden of proving no genuine issue for trial, the burden does not shift to the plaintiff to prove that her claim has a real chance of success...."
“How does a thoughtful libertarian address the potential issue of high social costs generated by legalization of hard drugs?” “Update: I see from the initial answers that many of you believe the social costs of hard drug use do not significant exceed the alternative costs when drugs remain illegal. Theoretically then, consider if it was... Continue Reading →
“How can marijuana ease and or lessen cancer?” This short documentary reviews the properties how cannabis exhibits that kills and prevents the spread of many cancers, this answer won’t deal with treating the unwanted direct effects of conventional cancer treatments or, how they are using cannabis with conventional treatments. So cannabinoids, the medicines in cannabis:... Continue Reading →
“What will the future of marijuana look like?” What a terrific question! It’s going to be like this… When the corporate funded Cannabis prohibition is over, it will be like the dawning of a whole new day! A new Era of Peace and Love and Healing! Here’s what we have now … How is... Continue Reading →
“After trying various high cbd to thc ratios of cannabis to treat my Crohn's disease, and failing, should I try a high THC-only strain? Not only are there thousands of strains of cannabis, there is a wide assortment of modes of ingestion, and types of refined cannabis medicines. So you tried a strain heaving in... Continue Reading →
By Kim Arnott Everyday legal problems — from getting divorced, to fighting eviction notices, to disputing cell phone bills — cost Canadians about $7.7 billion a year. But the physical, emotional and psychological consequences of these problems are also estimated to cost society about $800 million a year in healthcare and social services payments. The Canadian Forum on Civil... Continue Reading →
Keep up the great work! Can't wait for the story! OVERVIEW:  A newspaper reporter made a request to the Ministry of Health and Long-Term Care (the ministry) under the Freedom of Information and Protection of Privacy Act (the Act) for “an up-to-date breakdown of the amount of money each pharmaceutical company has... Continue Reading →